A-6G and A-20C Polymorphisms in the Angiotensinogen Promoter and Hypertension Risk in Chinese: a Meta-analysis

Overview

Journal PLoS One

Specialties General Medicine
Science

Date 2012 Jan 5

PMID 22216295

Citations 3

Authors

Wei Gu

Jielin Liu

Qiuli Niu

Hao Wang

Yuqing Lou

Kuo Liu

Lijuan Wang

Zuoguang Wang

Jingmei Zhang

Shaojun Wen

Affiliations

Soon will be listed here.

Abstract

Background: Numerous studies in Chinese populations have evaluated the association between the A-6G and A-20C polymorphisms in the promoter region of angiotensinogen gene and hypertension. However, the results remain conflicting. We carried out a meta-analysis for these associations.

Methods And Results: Case-control studies in Chinese and English publications were identified by searching the MEDLINE, EMBASE, CNKI, Wanfang, CBM, and VIP databases. The random-effects model was applied for dichotomous outcomes to combine the results of the individual studies. We finally selected 24 studies containing 5932 hypertensive patients and 5231 normotensive controls. Overall, we found significant association between the A-6G polymorphism and the decreased risk of hypertension in the dominant genetic model (AA+AG vs. GG: P=0.001, OR=0.71, 95%CI 0.57-0.87, P(heterogeneity)=0.96). The A-20C polymorphism was significantly associated with the increased risk for hypertension in the allele comparison (C vs. A: P=0.03, OR=1.14, 95%CI 1.02-1.27, P(heterogeneity)=0.92) and recessive genetic model (CC vs. CA+AA: P=0.005, OR=1.71, 95%CI 1.18-2.48, P(heterogeneity)=0.99). In the subgroup analysis by ethnicity, significant association was also found among Han Chinese for both A-6G and A-20C polymorphisms. A borderline significantly decreased risk of hypertension between A-6G and Chinese Mongolian was seen in the allele comparison (A vs. G: P=0.05, OR=0.79, 95%CI 0.62-1.00, P(heterogeneity)=0.84).

Conclusion: Our meta-analysis indicated significant association between angiotensinogen promoter polymorphisms and hypertension in the Chinese populations, especially in Han Chinese.

Citing Articles

The Genetic Variants in the Renin-Angiotensin System and the Risk of Heart Failure in Polish Patients.

Goracy I, Goracy A, Kaczmarczyk M, Rosik J, Lewandowska K, Ciechanowicz A Genes (Basel). 2022; 13(7).

PMID: 35886041 PMC: 9319667. DOI: 10.3390/genes13071257.

Association of mononucleotide polymorphisms of angiotensinogen gene at promoter region with antihypertensive response to angiotensin receptor blockers in hypertensive Chinese.

Gong H, Mu L, Zhang T, Xu X, Du F J Renin Angiotensin Aldosterone Syst. 2019; 20(1):1470320319827205.

PMID: 30798697 PMC: 6362516. DOI: 10.1177/1470320319827205.

Identifying potential functional impact of mutations and polymorphisms: linking heart failure, increased risk of arrhythmias and sudden cardiac death.

Jagu B, Charpentier F, Toumaniantz G Front Physiol. 2013; 4:254.

PMID: 24065925 PMC: 3778269. DOI: 10.3389/fphys.2013.00254.

References

Munafo M, Flint J . Meta-analysis of genetic association studies. Trends Genet. 2004; 20(9):439-44. DOI: 10.1016/j.tig.2004.06.014. View

Niu W, Qi Y . Association of α-adducin and G-protein β3 genetic polymorphisms with hypertension: a meta-analysis of Chinese populations. PLoS One. 2011; 6(2):e17052. PMC: 3045422. DOI: 10.1371/journal.pone.0017052. View

Perazella M, Setaro J . Renin-angiotensin-aldosterone system: fundamental aspects and clinical implications in renal and cardiovascular disorders. J Nucl Cardiol. 2003; 10(2):184-96. DOI: 10.1067/mnc.2003.392. View

Liu Y, Qin W, Hou S, Shan G, Zhuo M, Chen Y . A-6G variant of the angiotensinogen gene and essential hypertension in Han, Tibetan, and Yi populations. Hypertens Res. 2001; 24(2):159-63. DOI: 10.1291/hypres.24.159. View

Velez D, Guruju M, Vinukonda G, Prater A, Kumar A, Williams S . Angiotensinogen promoter sequence variants in essential hypertension. Am J Hypertens. 2006; 19(12):1278-85. DOI: 10.1016/j.amjhyper.2006.05.020. View

Hilgers K, Delles C, Veelken R, Schmieder R . Angiotensinogen gene core promoter variants and non-modulating hypertension. Hypertension. 2001; 38(6):1250-4. DOI: 10.1161/hy1201.096545. View

Jeunemaitre X, Soubrier F, Kotelevtsev Y, Lifton R, Williams C, Charru A . Molecular basis of human hypertension: role of angiotensinogen. Cell. 1992; 71(1):169-80. DOI: 10.1016/0092-8674(92)90275-h. View

Easterbrook P, Berlin J, Gopalan R, Matthews D . Publication bias in clinical research. Lancet. 1991; 337(8746):867-72. DOI: 10.1016/0140-6736(91)90201-y. View

Jiang X, Sheng H, Li J, Xun P, Cheng Y, Huang J . Association between renin-angiotensin system gene polymorphism and essential hypertension: a community-based study. J Hum Hypertens. 2008; 23(3):176-81. DOI: 10.1038/jhh.2008.123. View

10.

Higgins J, Thompson S, Deeks J, Altman D . Measuring inconsistency in meta-analyses. BMJ. 2003; 327(7414):557-60. PMC: 192859. DOI: 10.1136/bmj.327.7414.557. View

11.

Qi Y, Niu W, Zhou W, Hou S, Qiu C . Correlation between angiotensinogen gene polymorphisms and essential hypertension in Chinese population. J Hum Hypertens. 2007; 22(2):147-50. DOI: 10.1038/sj.jhh.1002282. View

12.

Lau J, Ioannidis J, Schmid C . Quantitative synthesis in systematic reviews. Ann Intern Med. 1998; 127(9):820-6. DOI: 10.7326/0003-4819-127-9-199711010-00008. View

13.

Jain S, Tillinger A, Mopidevi B, Pandey V, Chauhan C, Fiering S . Transgenic mice with -6A haplotype of the human angiotensinogen gene have increased blood pressure compared with -6G haplotype. J Biol Chem. 2010; 285(52):41172-86. PMC: 3003415. DOI: 10.1074/jbc.M110.167585. View

14.

Gui-yan W, Yan-hua W, Qun X, Wei-jun T, Ming-ling G, Jian W . Associations between RAS Gene polymorphisms, environmental factors and hypertension in Mongolian people. Eur J Epidemiol. 2006; 21(4):287-92. DOI: 10.1007/s10654-005-6006-4. View

15.

Li N, Zhou L, Wu W, Shi Y, Wang X, Wang J . [The relationship between the variants in 5' upstream core promoter A(-6)G and A(-20)C of angiotensinogen gene and essential hypertension in Kazakans of Xinjiang]. Zhonghua Yi Xue Yi Chuan Xue Za Zhi. 2004; 21(1):23-8. View

16.

Kurtz T, Spence M . Genetics of essential hypertension. Am J Med. 1993; 94(1):77-84. DOI: 10.1016/0002-9343(93)90124-8. View

17.

Cavalli-Sforza L . The Chinese human genome diversity project. Proc Natl Acad Sci U S A. 1998; 95(20):11501-3. PMC: 33897. DOI: 10.1073/pnas.95.20.11501. View

18.

Niu W, Qi Y, Cen W, Cui C, Zhuoma C, Cai D . Genetic polymorphisms of angiotensinogen and essential hypertension in a Tibetan population. Hypertens Res. 2008; 30(11):1129-37. DOI: 10.1291/hypres.30.1129. View

19.

Chen X, Wang S, Wang X, Lu M, Jin L . [Study on the association of predisposing genes with essential hypertension among Kazakhs ethnic group in Xinjiang]. Zhonghua Liu Xing Bing Xue Za Zhi. 2008; 29(8):752-6. View

20.

Chalmers I . Underreporting research is scientific misconduct. JAMA. 1990; 263(10):1405-8. View